Finland's MAs to be cancelled under "sunset clause"
This article was originally published in Scrip
Executive Summary
Finland national agency for medicines (NAM) has warned that up to 1,000 pharmaceutical marketing authorisations may lapse under the “sunset clause” in November. The agency will publish a list of lapsed authorisations on its website on November 14th.